Marinus Pharmaceuticals reported $70.78M in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
ALKERMES ALKS:US USD 293.9M 633K
Amgen AMGN:US USD 38.94B 241M
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 998M
Eisai 4523:JP JPY 94.91B 8M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Supernus Pharmaceuticals SUPN:US USD 401.44M 529K
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 33.59M 605K